vTv Therapeutics stockholders elect seven directors and ratify Ernst & Young as auditor for 2025

vTv Therapeutics Inc.

All seven director nominees elected: Srinivas Akkaraju, Raymond Cheong, Fahed Al Marzooqi, Richard S. Nelson, Anne Phillips, Paul Sekhri, Daniel K. Spiegelman.
Votes for director nominees ranged from 2.07M to 2.18M shares; broker non-votes of 219,013 on each.
Ratification of Ernst & Young as independent auditor: 2,400,291 For, 3,852 Against, 1,416 Abstain, 0 broker non-votes.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.